Susan Sutherland

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis et al. · Journal of Clinical Oncology · 2010 · 842 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

Aliya Khan, George K.B. Sándor, Edward Dore et al. · PubMed · 2008 · 204 citations

Dentistry, Oral Pathology, Oral Surgery +12

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.

A Ludwicka, T. Ohba, Maria Trojanowska et al. · PubMed · 1995 · 152 citations

Veterinary Medicine, Pathobiology, Pathology +17

Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results

Alan P. Venook, Donna Niedzwiecki, Donna Hollis et al. · Journal of Clinical Oncology · 2006 · 115 citations

Medicine, Oncology, Pharmacotherapy +17

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

Todd L. Demmy, Lin Gu, Jack E. Burkhalter et al. · Journal of the National Comprehensive Cancer Network · 2012 · 107 citations

Medicine, Surgery, Chemotherapy +15